The epidemiology of bacterial sepsis

被引：80

作者：

Rangel-Frausto, MS

机构：

[1] Inst Nacl Nutr Salvador Zubiran, Div Hosp Epidemiol, Mexico City 14000, DF, Mexico

[2] Natl Med Ctr, Hosp Epidemiol Res Unit, Mexico City, DF, Mexico

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 1999年 / 13卷 / 02期

关键词：

D O I：

10.1016/S0891-5520(05)70076-3

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

As a result of better understanding of pathogenesis, new definitions of sepsis have been proposed, and the complexity of this syndrome is clearer. Population-based studies of bloodstream infections-what now is called sepsis-have helped us to understand the natural history of this very frequent problem. The mortality and morbidity of each of the systemic inflammatory response syndrome stages have been described; our ability to better understand and predict these stages will help us to make better therapeutic decisions.

引用

页码：299 / +

页数：15

共 55 条

[11] INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS [J].

BRUNBUISSON, C ;

DOYON, F ;

CARLET, J ;

DELLAMONICA, P ;

GOUIN, F ;

LEPOUTRE, A ;

MERCIER, JC ;

OFFENSTADT, G ;

REGNIER, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :968-974

[12]

*CDC, 1983, MMWR-MORBID MORTAL W, V32, pS1

[13]

*CDC, 1984, MMWR-MORBID MORTAL W, V33, pS9

[14]

*CDC, 1975, NAT NOS INF STUD REP

[15]

*CDCP, 1990, MMWR-MORBID MORTAL W, V39, P31

[16]

[Centers for Disease Control and Prevention National Center for Health Statistics], 1993, MONTHLY VITAL STAT R, V41, P45

[17] Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality [J].

Edmond, MB ;

Ober, JF ;

Dawson, JD ;

Weinbaum, DL ;

Wenzel, RP .

CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) :1234-1239

[18] Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127) - Results of a randomized, double-blind, placebo-controlled trial [J].

Fein, AM ;

Bernard, GR ;

Criner, GJ ;

Fletcher, EC ;

Good, JT ;

Knaus, WA ;

Levy, H ;

Matuschak, GM ;

Shanies, HM ;

Taylor, RW ;

Rodell, TC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (06) :482-487

[19] Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein [J].

Fisher, CJ ;

Agosti, JM ;

Opal, SM ;

Lowry, SF ;

Balk, RA ;

Sadoff, JC ;

Abraham, E ;

Schein, RMH ;

Benjamin, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1697-1702

[20] SEPTICEMIA IN 980 PATIENTS AT A UNIVERSITY HOSPITAL IN BERLIN - PROSPECTIVE STUDIES DURING 4 SELECTED YEARS BETWEEN 1979 AND 1989 [J].

GEERDES, HF ;

ZIEGLER, D ;

LODE, H ;

HUND, M ;

LOEHR, A ;

FANGMANN, W ;

WAGNER, J .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (06) :991-1002

← 1 2 3 4 5 6 →